U.S. Health Secretary Robert F. Kennedy Jr. has named eight new members to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), following the abrupt dismissal of all 17 prior members. The newly appointed panel includes several figures known for expressing skepticism about vaccines, particularly mRNA technology.
Among the new appointees is Robert Malone, a vocal critic of mRNA COVID-19 vaccines and an ally of Kennedy’s "Make America Healthy Again" movement. Other members include Joseph Hibbeln, Martin Kulldorff, Retsef Levi, Cody Meissner, James Pagano, Vicky Pebsworth, and Michael Ross—some of whom have ties to prior CDC or FDA vaccine panels, while others have promoted views critical of current vaccination practices.
Kennedy, who has long challenged vaccine safety despite scientific consensus, claimed the former panel had conflicts of interest, although he did not provide specific evidence. He emphasized the reshuffle was meant to “restore public trust in vaccine science.”
The new ACIP members will participate in the committee’s June 25–27 meeting, where decisions are expected on vaccine recommendations for flu shots and the 2025–26 COVID-19 boosters. The meeting agenda has yet to be released.
The move sparked market reactions: Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) shares dipped slightly, while Novavax (NASDAQ:NVAX), which produces a non-mRNA COVID-19 vaccine, saw a marginal rise.
Concerns remain about the vetting process for the new members. Some, like Pebsworth and Meissner, have served on FDA advisory committees, while others, such as Levi and Kulldorff, have made controversial statements questioning mRNA vaccine safety.
Despite FDA confirmation that mRNA vaccines are safe and effective, Kennedy’s overhaul has intensified the national debate on vaccine policy and public health strategy.


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit
Cuba Receives Humanitarian Aid Convoy Amid U.S. Sanctions
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Iran-U.S. Negotiations: Tehran Reviews American Peace Proposal Amid Ongoing Gulf Conflict
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Russia Strikes Kharkiv and Izmail as Cross-Border Drone War Escalates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Bachelet Pushes Forward With UN Secretary-General Bid Despite Chile's Withdrawal
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield
US-Iran Ceasefire Talks Underway: What You Need to Know
Explosion and Fire Erupt at Valero Oil Refinery in Port Arthur, Texas 



